There Is Need To Increase Awareness About Clinical Research That Has Done Good For Patients
The Indian Society for Clinical Research (ISCR), an association of clinical research professionals, has announced the appointment of Dr Chirag Trivedi as its President for the term 2017-19. Dr Trivedi takes over the reins from Suneela Thatte who was President for two terms from 2013-217. He, who holds a doctorate in Pharmacology and has worked across the biopharma industry for over 14 years, brings rich and varied clinical research experience to his role as President of ISCR. As President, he is responsible for spearheading ISCR’s efforts to build awareness of clinical research as a specialty in India and to facilitate its growth in the country, while helping to evolve the highest standards of quality and ethics. He was earlier the co-chair of the Investigator Council of ISCR. In an interaction with BioSpectrum he has shared his views about the future of clinical research in India. Excerpts of the interview
How do you see the future of Indian clinical research?
We have had a lot of changes in the regulation which is making the regulations more robust, transparent and predictable. These changes have helped us to make a more vigorous framework from where we can lead India further for more efficient clinical research. As I said earlier obviously we need to have drugs that will be developed in India and for that we will need to be ready with all statements of the ethic committee, investigators, CROs, Pharma companies and the Regulators. Everybody needs to work together towards this common goal.
How has the change in norms affected clinical trials in India? Has the scenario improved?
Denne historien er fra July 2017-utgaven av Bio Spectrum.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra July 2017-utgaven av Bio Spectrum.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Sartorius Stedim Biotech opens new centre for bioprocess innovation in US
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.
Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research
Agilent Technologies Inc. has announced the new MitorOCR Assay Kit.
Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data
Qiagen has announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.
Parse Biosciences announces expansion of Evercode BCR product line
Parse Biosciences, a leader in scalable single cell sequencing solutions, has announced the expansion of its Evercode BCR product line to enable applications in mice.
New technology for unambiguous detection of HIV genome using tailored fluorogenic tests
A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.
Gene mutation likely cause for developing autism in early childhood: RGCB study
Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.
IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing
A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.
RSSDI study lays focus on Yoga and Diabetes Prevention
Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, recently released the landmark study by Research Society for Study of Diabetes in India (RSSDI) on 'Yoga and Diabetes Prevention'.
Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare
RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).
Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser
Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser.
